SCHEMBL8356293

SCHEMBL8356293

CCCCCCC(NC(=O)Cc1c(C)n(Cc2ccccc2)c2ccc(OC)cc12)C(=O)N(C)CCCC

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 19/20 0.61
PLA2G1B P04054 1/20 0.58
MEN1 O00255 1/20 0.50
RGS12 O14924 1/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
CYP2C9 P11712 1/20 0.50
PKM P14618 1/20 0.50
TSHR P16473 1/20 0.50
NFKB1 P19838 1/20 0.50
MAPK1 P28482 1/20 0.50
CYP2C19 P33261 1/20 0.50
GNAI1 P63096 1/20 0.50
PMP22 Q01453 1/20 0.50
KMT2A Q03164 1/20 0.50
HIF1A Q16665 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8358976 0.93 PLA2G2A (0.64) PLA2G2APLA2G1BMEN1RGS12ALDH1A1
SCHEMBL8356918 0.92 PLA2G2A (0.51) PLA2G2APLA2G1B
SCHEMBL8356782 0.92 PLA2G2A (0.61) PLA2G2APLA2G1BMEN1RGS12ALDH1A1
SCHEMBL8356964 0.92 PLA2G2A (0.50) PLA2G2APLA2G1B
SCHEMBL8354405 0.91 PLA2G2A (0.65) PLA2G2APLA2G1BMEN1KMT2A
SCHEMBL8356688 0.91 PLA2G2A (0.54) PLA2G2APLA2G1BMEN1ALDH1A1LMNA
SCHEMBL8360250 0.88 PLA2G2A (0.47) PLA2G2APLA2G1BLMNACYP1A2CYP3A4
SCHEMBL8356464 0.86 PTGS2 (0.47) PLA2G2A
SCHEMBL8360290 0.86 PLA2G2A (0.54) PLA2G2AALDH1A1CYP1A2CYP2C19
SCHEMBL8354810 0.86 LMNA (0.58) PLA2G2ALMNACYP1A2CYP2C9TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877202-A Indole derivatives useful to treat estrogen-related neoplasms and disorders AVENTISUB II INC. 1999-03-02 US disclosed